Meningococcal carriage and disease--population biology and evolution.
Caugant DA, Maiden MC. · 2009
Read Meningococcal carriage and disease--population biology and evolution. by Caugant DA, Maiden MC. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2719693.txt.
Introduction
Caugant and Maiden reviewed in 2009 the population biology of Neisseria meningitidis, a bacterium that lives harmlessly in the human throat but can cause severe meningococcal disease. Carriage is common, with most people colonized at some point in life, yet invasive disease is rare. Molecular studies show carried strains are hugely diverse, which raises a puzzle about how virulent types persist.
Only a limited set of genetic types, called hyperinvasive lineages, cause most disease worldwide. Models with positive selection, where fitter types spread, can explain how those lineages endure inside a diverse, mostly harmless population. The authors stress that vaccine design, especially for parts under the capsule, must reckon with this population structure.
Catalog record
| CREATOR | Caugant DA, Maiden MC. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Meningococcal carriage and disease—Population biology and evolution By Dominique A. Caugant, Martin C.J. Maiden Published in: Vaccine DOI: 10.1016/j.vaccine.2009.04.061 ABSTRACT Meningococcal disease occurs worldwide with incidence rates varying from 1 to 1000 cases per 100,000. The causative organism, Neisseria meningitidis, is an obligate commensal of humans, which normally colonizes the mucosa of the upper respiratory tract without causing invasive disease, a phenomenon known as carriage. Studies using molecular methods have demonstrated the extensive genetic diversity of meningocococci isolated from carriers, in contrast to a limited number of genetic types, known as the hyperinvasive lineages, associated with invasive disease. Population and evolutionary models that invoke positive selection can be used to resolve the apparent paradox of virulent lineages persisting during the global spread of a non-clonal and normally commensal bacterium. The application of insights gained from studies of meningococcal population biology and evolution is important in understanding the spread of disease, as well as in vaccine development and implementation, especially with regard to the challenge of producing comprehensive vaccines based on sub-capsular antigens and measuring their effectiveness. INTRODUCTION The sole ecological niche of Neisseria meningitidis is the mucosa of the oropharynx of humans. Meningococcal colonization of the respiratory tract, a phenomenon commonly referred to as carriage, represents a successful commensal relationship between the host and the bacterium, with the host experiencing no detectable pathology. On the other hand disease represents a failed or dysfunctional relationship with the host [1]. Acquisition of N. meningitidis demands person-to-person transmission via direct contact or through dispersion of respiratory droplets from an infected to a susceptible individual. Although often protected by a polysaccharide capsule, meningococci are particularly sensitive to desiccation; thus, spread from one individual to another requires close contact [2]. In closed or semi-closed settings, such as residential schools and military recruit camps, transmission increases dramatically and carriage prevalence may approach 100% [3,4]. While carriage rates are very variable among human populations, point-prevalence carriage rates in Europe and the United States have been estimated to range from 10 to 35% in young adults [5–8] and it is likely that, at one time or another during life, most individuals are colonized with meningococci. As is the case with other bacterial inhabitants of the mucosa, such as Haemophilus influenzae and Streptococcus pneumoniae, N. meningitidis has a clear pathogenic potential. Shortly after colonization, and usually less than 10 days from first exposure, meningococci can pass through the epithelial cells and enter the blood stream, where they occasionally survive and multiply intravascularly. Progression to severe meningococcal disease can occur very rapidly. The most important factors predisposing individuals to invasive meningococcal disease are the lack of circulating protective bactericidal antibodies and defects in the complement system. From the blood stream the bacterium is then disseminated to various organs and more than half of the patients developing a systemic meningococcal infection will present with clinical symptoms of meningitis [9]. Meningococcal disease is a life-threatening illness and, despite appropriate treatment, the case fatality rate is still around 10% [10]. MENINGOCOCCAL CARRIAGE Studies of meningococci isolated from the nasopharynx, which is the normal environment of the meningococcus, are essential to improve knowledge of the epidemiology of meningococcal disease. The results of carriage studies, however, are highly dependent on the swabbing techniques and laboratory methods used. Swabbing of the posterior wall of the oropharynx, followed by immediate cultivation on selective medium, is the recommended procedure to detect asymptomatic meningococcal carriage in an individual [11]. Some real-time PCR methods have been attempted more recently, but their sensitivity is not greater than the microbiological techniques based on culture [12,13]. Age is one of the most important factors influencing meningococcal carriage rates. In Europe and North America, carriage rates are very low in the first years of life, and then sharply increase in teenagers, reaching a maximum in those aged between 20 and 24 years. Carriage rates in older ages are lower than 10% [5,6,8,14]. Studies of meningococcal carriage in Africa, on the other hand, have shown very variable age distributions from one study to another that usually do not correspond to those from Europe and North America [15]. Other factors that increase the risk of being a meningococcal carrier include: male gender; coincident respiratory tract infections of viral or bacterial origin; active as well as passive smoking; and low socio-economic status. One of the most important factors is the number and closeness of social contacts [16]. Most carrier studies are cross-sectional surveys of a target population at a single point in time, i.e. are snapshot studies. In such cases, a positive sample will not identify when the individual acquired the meningococcus and a negative sample might be due to low sampling sensitivity. Some investigators, however, have attempted to measure duration of meningococcal carriage by following subjects with repeated throat samples over time in longitudinal studies. These studies have shown that the meningococcal carrier state may be chronic, lasting for several months, intermittent, or transient [17,18]. To understand the dynamics of transmission of N. meningitidis in a population, molecular characterization of the organisms is essential. In most carriage studies, isolate characterization to determine whether the carried strain is the same over time, has either not been performed or the methods employed were relatively insensitive. In the past few years a number of longitudinal studies have employed powerful molecular methods to gain information on the duration of carriage and acquisition rates in populations. These investigations have shown that the commensal association of particular strain with the host is a long-term relationship with 90% of stable carriers keeping the same strain for a period of 5–6 months [19,20]. Longer follow-up periods are required to establish the duration of carriage fully. Duration of carriage depends on the properties of the colonizing strain, and not all meningococcal strains having the same propensity to establish a long-term commensal relationship with a given host. MENINGOCOCCAL DISEASE Despite high rates of meningococcal carriage in many or most human populations, disease is rare with annual incidence rates that vary from 1 to 1000 cases per 100,000 individuals in different parts of the world. With the exception of patients with complement deficiency, who are predisposed to meningococcal infections, immunocompetent individuals are unlikely to develop the disease more than once. Meningococcal disease in Europe and North America usually occurs as sporadic cases and the highest age-specific incidence rates are seen in children less than 5 years of age, which is in contrast to the low prevalence of asymptomatic carriage in this age group. The disease may also present different epidemiological features. In some areas hyperendemic disease occurs, with incidence rates of 5–10 cases per 100,000 and these increased incidence waves can last for several decades. Cases can also occur in clusters and localized outbreaks, but the most dramatic epidemiological manifestations are the periodic large countrywide epidemics or pandemics that occur in some parts of the world. Currently, epidemic and pandemic disease appears restricted to countries of sub-Saharan Africa, in the so-called “meningitis belt”, which extends from Ethiopia in the East to Senegal in the West [21]. The capsular polysaccharide is the outermost structure on the meningococcal surface. Of the 12 serogroups identified on the basis of antigenic variation of the capsule, 5 (A, B, C, W135, and